Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Phase Ib study of PRT543, an oral protein arginine methyltransferase 5 (PRMT5) inhibitor, in patients with advanced splicing factor-mutant myeloid malignancies.
Journal: Leukemia
Published: October 11, 2024
Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Phase 1b Trial.
Journal: Clinical lymphoma, myeloma & leukemia
Published: November 14, 2023
Simultaneous Cases of Carfilzomib-Induced Thrombotic Microangiopathy in 2 Patients With Multiple Myeloma.
Journal: Federal practitioner : for the health care professionals of the VA, DoD, and PHS
Published: November 25, 2022
Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial.
Journal: Blood
Published: March 23, 2022
Treatment patterns and outcomes according to cytogenetic risk stratification in patients with multiple myeloma: a real-world analysis.
Journal: Blood cancer journal
Published: October 27, 2021
Combination of Atezolizumab and Tazemetostat in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results From a Phase Ib Study.
Journal: Clinical lymphoma, myeloma & leukemia
Published: October 08, 2021
Combination of Atezolizumab and Obinutuzumab in Patients with Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-Cell Lymphoma: Results from a Phase 1b Study.
Journal: Clinical lymphoma, myeloma & leukemia
Published: October 08, 2021
A systematic review of higher-risk myelodysplastic syndromes clinical trials to determine the benchmark of azacitidine and explore alternative endpoints for overall survival.
Journal: Leukemia research
Published: January 20, 2021
Last Updated: 09/26/2026